Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation
Author(s):
Schetelig, J.; Wreede, L.C. de (0000-0002-7667-9369); Gelder, M. van; Andersen, N.S.; Moreno, C.; Vitek, A.; Karas, M.; Michallet, M.; Machaczka, M.; Gramatzki, M.; Beelen, D.; Finke, J.; Delgado, J.; Volin, L.; Passweg, J.; Dreger, P.; Henseler, A.; Biezen, A. van; Bornhauser, M.; Schonland, S.O.; Kroger, N.; CLL Subcomm; Chronic Malignancies Working Party
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-04-30
Language
English
Is part of
Bone Marrow Transplantation (2017), Vol. 52, no. 4, p. 552-560
